Menu

Impact Events

More
Date Lead Company Event Type Approval Change Approval Likelihood
6/3/26 Roche (RO) Zelboraf for Colorectal Cancer (CRC) Subscribers Only Subscribers Only Subscribers Only
6/3/26 Shanghai Kechow Pharma tunlametinib for Colorectal Cancer (CRC) Subscribers Only Subscribers Only Subscribers Only
6/2/26 AstraZeneca (AZN) camizestrant for Breast Cancer Subscribers Only Subscribers Only Subscribers Only
6/2/26 AstraZeneca (AZN) camizestrant for HR+/HER2- Breast Cancer Subscribers Only Subscribers Only Subscribers Only
6/2/26 Celcuity (CELC) gedatolisib for HR+/HER2- Breast Cancer Subscribers Only Subscribers Only Subscribers Only

Upcoming Catalysts

More
Expected Date Range Lead Company Drug Expected Catalyst
06/25/2025 Subscribers Only Subscribers Only Company - Analyst/R&D Update
06/25/2025 Subscribers Only Subscribers Only Company - Analyst/R&D Update
06/26/2025 Subscribers Only Subscribers Only Company - Analyst/R&D Update
09/08/2025 Subscribers Only Subscribers Only Company - Analyst/R&D Update
09/17/2025 Subscribers Only Subscribers Only Company - Analyst/R&D Update